Since neutralizing and antibody-dependent cellular cytotoxicity-inducing activity of antibodies against HTLV-1 Env gp46 have been reported to prevent viral infection in vitro [52], less robust antibody response for HTLV-1 Env may fail to control viral infection in the CNS of HAM/TSP patients. Here, ERVW-1 is linked to tropical spastic paraparesis.